Zilurgisertib
Product Specifications
UNSPSC Description
Zilurgisertib (INCB-000928; NBU-928) is a selective ALK 2 inhibitor for researching diseases such as cancer.
Target Antigen
TGF-β Receptor
Type
Reference compound
Related Pathways
TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zilurgisertib.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=CC=C(C=C2)[C@]3(CN(C4CCOCC4)C5)[C@]5([H])C3)=CN=C1N)NC(CC6)(CC7)CCC67O
Molecular Weight
502.65
References & Citations
[1]Li J, et al. Preparation of aminopyridine derivatives and their use as selective ALK-2 inhibitors. WO2018014829 A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145608/Zilurgisertib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145608/Zilurgisertib-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2173389-57-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal EBI3 Antibody (10J803) [Alexa Fluor 350]](https://cdn.genprice.uk/genprice/genprice2.png)
BUB1 (Budding Uninhibited by Benzimidazoles 1, BUB1A, BUB1L, HBUB1) (FITC)
BUB1 (Budding Uninhibited by Benzimidazoles 1, BUB1A, BUB1L, HBUB1) (FITC)